Neuroendocrine Tumour Imaging and Molecular Radiotherapy

Neuroendocrine tumours are a diverse group of relatively rare cancers, with a reported incidence of 9 cases per 100,000 people in 2015.

Recently there have been major advances in their diagnosis, staging and treatment.  The possibility of multiple options to investigate and treat a diverse range of rare tumours represents a challenge for all members of the MDT, not least the radiologist.

The course aims to demystify this disease group and help radiologists achieve optimal management of their patients at the MDT.

It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorials.

Suitable for radiologists and nuclear medicine physicians who intend to train to report on neuroendocrine tumours, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT.